ENVALITH
コタ株式会社 logo

COTA CO., LTD.

4923Prime MarketChemicals

コタ株式会社 logo
COTA CO., LTD.4923
Reference Indicators

Market Cap

397¥100M

P/E (Forecast)

27.6x

P/B

3.0x

Dividend Yield (Forecast)

1.63%

ROE

12.3%

EV/EBITDA

14.6x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
8,6918,8049,1369,3769,604
Cost of Sales
2,4842,5242,7612,8542,941
Gross Profit
6,2076,2796,3756,5216,662
SG&A Expenses
4,0554,2594,4534,6894,667
Operating Income
2,1512,0201,9211,8311,995
Non-operating Income
32121342979
Non-operating Expenses
6263279
Ordinary Income
2,1772,1151,9531,8342,065
Extraordinary Income
32
Extraordinary Losses
15827
Pre-tax Income
2,0192,1481,9531,8342,038
Income Taxes
626587603529602
Net Income
1,3931,5601,3491,3041,435
EBITDA
2,3662,3012,2662,1992,305
Gross Margin
71.4%71.3%69.8%69.6%69.4%
Operating Margin
24.8%22.9%21.0%19.5%20.8%
ROA
10.7%11.4%9.1%8.8%9.1%
ROE
15.4%15.8%12.7%11.7%12.3%